Beauty Health (NASDAQ:SKIN) Stock Rating Upgraded by Zacks Research

Beauty Health (NASDAQ:SKIN) was upgraded by equities research analysts at Zacks Research from a “hold” rating to a “strong-buy” rating in a report issued on Monday,Zacks.com reports.

Several other analysts also recently weighed in on SKIN. Canaccord Genuity Group cut their price target on Beauty Health from $1.50 to $1.00 and set a “hold” rating on the stock in a research note on Friday, May 1st. Roth Capital reiterated a “buy” rating and set a $2.00 price objective (down from $2.50) on shares of Beauty Health in a research note on Wednesday, May 20th. TD Cowen dropped their target price on Beauty Health from $1.65 to $1.50 and set a “hold” rating on the stock in a report on Monday, March 16th. Finally, Weiss Ratings upgraded Beauty Health from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, July 8th. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Beauty Health has a consensus rating of “Hold” and a consensus price target of $2.02.

Beauty Health Price Performance

Shares of SKIN opened at $0.86 on Monday. The stock has a market cap of $111.84 million, a PE ratio of -5.08 and a beta of 1.08. The company has a debt-to-equity ratio of 4.37, a quick ratio of 1.48 and a current ratio of 1.79. Beauty Health has a fifty-two week low of $0.55 and a fifty-two week high of $2.69. The firm’s 50-day simple moving average is $0.72 and its two-hundred day simple moving average is $1.00.

Beauty Health (NASDAQ:SKIN) last announced its earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.09) by $0.04. Beauty Health had a negative net margin of 2.03% and a negative return on equity of 9.38%. The business had revenue of $64.91 million during the quarter, compared to the consensus estimate of $66.28 million. Analysts anticipate that Beauty Health will post -0.14 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Beauty Health

Several hedge funds and other institutional investors have recently modified their holdings of SKIN. Capricorn Fund Managers Ltd acquired a new position in Beauty Health during the 1st quarter valued at about $17,270,000. Woodline Partners LP boosted its stake in Beauty Health by 255.9% during the 3rd quarter. Woodline Partners LP now owns 5,930,027 shares of the company’s stock valued at $11,801,000 after purchasing an additional 4,263,997 shares in the last quarter. Millennium Management LLC grew its holdings in Beauty Health by 127.0% during the fourth quarter. Millennium Management LLC now owns 5,764,802 shares of the company’s stock worth $8,013,000 after acquiring an additional 3,225,668 shares during the period. Mirabella Financial Services LLP grew its stake in shares of Beauty Health by 21.3% in the 3rd quarter. Mirabella Financial Services LLP now owns 15,596,277 shares of the company’s stock worth $31,037,000 after purchasing an additional 2,734,728 shares during the last quarter. Finally, Soleus Capital Management L.P. acquired a new position in Beauty Health in the second quarter worth approximately $1,910,000. 93.26% of the stock is currently owned by hedge funds and other institutional investors.

Beauty Health Company Profile

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.